RSV IMMUNISATION

Clinical trials for RSV IMMUNISATION explained in plain language.

Never miss a new study

Get alerted when new RSV IMMUNISATION trials appear

Sign up with your email to follow new studies for RSV IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 2

Scientists test RSV shot in most vulnerable elderly

⭐️ VACCINE ⭐️ Recruiting now

This study is testing how well the approved RSV vaccine Arexvy works in adults aged 80 and older compared to those aged 60-65. Researchers want to see if the vaccine produces a strong immune response in the most elderly and frail populations, who are at highest risk for severe RS…

Matched conditions: RSV IMMUNISATION

Phase: PHASE3 • Sponsor: Karin Karin Loré • Aim: ⭐️ VACCINE ⭐️

Last updated Apr 01, 2026 14:41 UTC

RSV IMMUNISATION

Get alerted when new RSV IMMUNISATION trials appear

Scientists test RSV shot in most vulnerable elderly